规格: | 98% |
分子量: | 300.79 |
包装 | 价格(元) |
250mg | 电议 |
500mg | 电议 |
Background:
4-Chloro-7-(4-methylpiperazin-1-yl)pyrrolo[1,2-a]quinoxaline, a derivative of (E)-7-Fluoro-4-hydrazono-4,5-dihydropyrrolo[1,2-a]quinoxaline . an intermediate, which can be used in the synthesis of SC144. SC144 shows excellent potency against a panel of human cancer cell lines[1].
[1]. Plasencia C, et al. Discovery of a novel quinoxalinhydrazide with a broad-spectrum anticancer activity. Cancer Biol Ther. 2009 Mar;8(5):458-65.